Li Hui
Professor
genetics
Huazhong University of Science and Technology
China
Biography
M.D. in Pathogenic biology, 2005, Wuhan University M.S in Pathogenic biology, 2002, Wuhan University B.S. in Clinical medicine, 1998, Wuhan University
Research Interest
post-translational modification of proteins and their role in cancer
Publications
-
3. Wang N; Zhou Y ; Zheng LJ ; Li H. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. GYNECOLOGIC ONCOLOGY. 2014; 134:129-137.
-
2. Zeng, H ; Chen, YL ; You, WT ; Huang, XQ ; Zhou, CY ; Li, H miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ER alpha-positive breast cancer. FEBS LETTERS. 2015; 589: 812-821.
-
1. Chen, JX ; Liu, F ; Li H ; Archacld, S; Gao, M ; Liu, Y ; Liao, SJ ; Huang, M; Wang, JX ; Yu, SS; Li, C ; Tang, ZH ; Liu, MG. pVHL interacts with Ceramide kinase like (CERKL) protein and ubiquitinates it for oxygen dependent proteasomal degradation. CELLULAR SIGNALLING. 2015;27: 2314-2323.
